Formed from the merger of Candela and Syneron. Makes the GentleMax Pro (the most popular hair removal laser in the US), VBeam pulsed dye laser, and PicoWay tattoo removal platform. Owned by Apax Partners since 2017.
syneron candela is the medical-aesthetics company behind platforms including GentleMax Pro Plus, VBeam Prima, PicoWay, and Nordlys. Candela is privately owned by Apax Partners, and its long operating history makes it a serious vendor for practices that need durable equipment support, parts access, and a credible path for future service.
Candela is headquartered in Wayland, Massachusetts. Its best-known platform is GentleMax Pro, widely regarded as the most popular hair removal laser in the United States. That popularity shapes the buying case. A large installed base can make hiring, training, marketing, resale, and service less awkward than with a niche platform.
The catch is familiar to anyone shopping at the premium end of the market: the device is only part of the purchase. Warranty coverage, service response, handpiece condition, software access, financing terms, and trade-in language can change the value of a deal fast.
Syneron and Candela: How the Two Companies Became One
The Syneron Candela name reflects a merged company, not two competing manufacturers. That distinction matters because many buyers still use the legacy names when researching a laser platform, checking compatibility, looking for training, or trying to understand what happened to an older device.
Candela began as a laser manufacturer and built a reputation around hair removal and vascular technologies. Syneron developed its own identity in aesthetic energy devices, with platforms that remain familiar to many established practices. The combined company inherited both customer bases, product histories, and brand recognition.
Candela was founded in 1970 and has been building medical devices for 56 years, according to its Device Pulse Candela profile. That history does not guarantee that every older platform will receive the same level of support. It does make Candela a more established counterparty than a new manufacturer selling a single device with a thin service organization.
Legacy-device research deserves some care. A practice considering a used Syneron platform, an older Candela laser, or a discontinued system should ask a direct question before signing anything: can the seller document current parts availability and authorized service options? A lower purchase price can turn into a literal money pit when a handpiece, cooling component, or software issue cannot be resolved promptly.
The merged identity also changes how you should compare vendors. Do not treat “Syneron” and “Candela” as separate alternatives in a current purchase decision. Compare the relevant Candela platform against its direct category competitors, then evaluate the local support structure behind it.
Who Owns Candela Today
Candela has been owned by Apax Partners since 2017, according to its Device Pulse Candela profile. Apax is a private-equity firm, which means Candela does not provide the same level of public financial reporting as a publicly traded manufacturer.
That private structure creates an information gap for buyers. You cannot pull quarterly filings and use them to settle every question about revenue, debt, capital spending, or product investment. Practice owners are left with more practical evidence: the company’s operating history, installed base, product roadmap, service reputation, local field coverage, and willingness to put commitments in writing.
Private ownership is neither a reason to avoid Candela nor a reason to give it a pass. The question is whether the company can support the platform for the life of your ownership. A laser becomes a problem when its manufacturer cannot provide parts, training, service technicians, or software support when the schedule is full.
Candela’s longevity helps. Its major platforms are familiar to physicians, aesthetic providers, and patients. That can support utilization, especially for hair removal, vascular treatment, pigment work, and tattoo removal. A recognizable device name may also help a practice explain its treatment offering without inventing a new category from scratch.
Still, buyers should ask the local Candela representative for specifics. Who handles service in your market? What is the response-time commitment? Are loaner handpieces available? Which maintenance items are included? What happens if a critical component fails after the standard warranty expires?
Those answers matter more than a polished sales presentation. A company can have an established name and still leave a practice exposed through vague service language.
The Laser Lineup by Platform
Candela’s current lineup covers several major aesthetic treatment categories. Each platform carries a different clinical and commercial case, so buying the most famous name is not always the right move.
GentleMax Pro Plus
GentleMax Pro Plus is Candela’s flagship hair-removal platform. It also supports treatment plans involving pigmented lesions, vascular concerns, and other indications depending on configuration, training, and applicable clearance.
For a practice building around laser hair removal, this platform has an obvious advantage: market familiarity. Patients often recognize the GentleMax name, and many providers have prior experience with the technology. That can shorten the learning curve for a team and make it easier to market treatments without explaining an unfamiliar device category.
Read the GentleMax Pro Plus device profile before deciding whether its treatment mix, footprint, and ownership costs fit your practice.
The platform earns its premium when hair removal is a meaningful revenue line and the practice wants a device that can support more than one treatment category. It is less compelling when the practice only needs a narrow service or lacks enough local demand to keep a high-end system busy.
VBeam Prima
VBeam Prima is Candela’s pulsed dye laser platform for vascular-focused treatment. It is associated with concerns such as redness, visible vessels, and vascular lesions, subject to local regulatory requirements and clinical judgment.
Vascular lasers can be strategically useful because they serve a different patient need than a hair-removal platform. A practice with a strong dermatology, acne, rosacea, or redness-focused patient base may find that VBeam expands services in a more natural direction than a general-purpose platform.
The buying risk is utilization. A dedicated vascular laser needs a clear patient pipeline. If the practice cannot explain where the appointments will come from, the device can sit idle while its financing payment does not.
PicoWay is Candela’s picosecond platform, used for tattoo removal and pigment-focused treatments. It gives practices a way into a category where treatment outcomes, speed, and patient comfort can shape referrals and repeat business.
Tattoo removal can be attractive because the patient journey often involves multiple sessions. The platform also gives a practice another reason to keep patients in-house when they present with pigment concerns that fall outside a hair-removal treatment plan.
The commercial case depends on local competition. If several nearby practices already market tattoo removal aggressively, buying PicoWay without a clear differentiation plan can become an expensive attempt to copy a crowded menu. A practice with an underserved local market, referral relationships, or a strong pigment-treatment base has a better case.
The PicoWay device profile covers the platform’s role in tattoo removal and pigment treatment.
Nordlys
Nordlys is Candela’s multi-application platform for skin rejuvenation and light-based treatments. It can appeal to practices that want broader aesthetic flexibility without anchoring the entire purchase around a single flagship indication.
That flexibility can be useful for a practice with varied demand across complexion, texture, pigmentation, and vascular concerns. It can also make marketing simpler when the practice wants to sell a broader skin-health offering rather than a single laser service.
The tradeoff is focus. Broad platforms can create a menu with too many underdeveloped offerings. A practice should buy Nordlys because its providers have a plan for the treatments they intend to sell, not because versatility sounds reassuring in a sales demo.
Flagship Device Pricing
The list-price ranges below provide a starting point for comparison. They do not capture financing costs, included accessories, service coverage, training, consumables, local incentives, or the value of a trade-in.
Platform
Primary buying use case
List price
GentleMax Pro Plus
Hair removal and multi-indication laser treatments
GentleMax Pro Plus hair removal lasers list at $115,000-$175,000
Those ranges tell you where Candela sits in the market: premium equipment, premium capital commitment. The right comparison is not just list price against list price. Compare the expected treatment mix, provider confidence, local patient demand, maintenance requirements, and resale prospects.
A lower-priced platform can lose if it brings weaker demand, a smaller service network, or less useful clinical versatility. A higher-priced Candela system can lose if your practice cannot fill the schedule.
How to Negotiate a Candela Purchase
Most deals close at 10-20% below list for single-device purchases, according to its Device Pulse Candela profile. Treat that range as a conversation opener, not a guarantee.
The strongest negotiation position comes from preparation. Know which competing platforms you are considering, which treatments you expect to offer, and which deal terms are more valuable to you than a modest price cut. A rep can often protect headline price while giving ground on warranty, training, handpieces, marketing support, or payment structure.
Warranty is usually the first place to press. Ask for extended warranty coverage of 24-36 months instead of the standard 12, according to its Device Pulse Candela profile. That request is especially important for a practice buying its first major laser platform, where an unexpected repair can disrupt both cash flow and patient scheduling.
Get the warranty language in writing. Confirm whether labor, travel, replacement parts, calibration, handpieces, software updates, and loaner equipment are included. “Full coverage” can mean different things depending on the contract.
Trade-ins need the same scrutiny. A generous trade-in allowance can look good while the new-device price stays close to list. Ask for the value of the trade-in, the final device price, and every included item to appear separately in the proposal. You want to know whether Candela is paying fairly for your existing equipment or moving numbers around on the page.
Training matters too. A platform that the staff cannot use confidently will not produce the utilization assumed in the purchase model. Ask what training is included, whether additional training is available, and whether new hires can receive support later.
Strengths and Risk Profile
Candela wins on brand recognition, a broad device portfolio, and a meaningful installed base. GentleMax Pro Plus is particularly strong for practices where laser hair removal anchors the service mix. VBeam Prima, PicoWay, and Nordlys give the company credible platforms across vascular, pigment, tattoo-removal, and skin-rejuvenation work.
The company also benefits from its legacy identities. Candela and Syneron remain familiar names to many providers and patients, which can make a purchase feel less like a bet on an unknown manufacturer.
The main risk is the private-company information gap. Buyers cannot rely on public filings to assess operating performance in the way they might with a public manufacturer. They need to assess Candela through direct diligence: service coverage, warranty terms, local references, device availability, training quality, and the contract in front of them.
Used equipment introduces another layer of risk. Older Syneron and Candela platforms can offer a lower entry price, but only if service and parts remain available. A used deal without clear documentation on device condition, maintenance history, handpiece status, and support eligibility is not a bargain. It is a repair bill waiting for a busy week.
Candela is a sensible shortlist vendor for practices that want established aesthetic laser platforms and can support the capital outlay. The decision comes down to fit. Does the platform match the procedures your practice can sell, the patients it can attract, and the service terms it can live with after the rep leaves?
Frequently Asked Questions
Where is Candela (Syneron) headquartered?
Candela (Syneron) is headquartered in Wayland, MA. The company was founded in 1970 and currently operates in 100+. Annual revenue is approximately $500M+ (est.). The company has a private financial structure.
What devices does Candela (Syneron) make?
Candela (Syneron) produces devices across 4 categories: laser hair removal, vascular pigment, tattoo removal, skin rejuvenation. Key technologies include Alexandrite Laser, Nd:YAG Laser, Pulsed Dye Laser, Picosecond Laser. The current US-market device lineup includes GentleMax Pro Plus, VBeam Prima, PicoWay, Nordlys.
Is Candela (Syneron) financially stable?
Candela (Syneron) reports approximately $500M+ (est.) in annual revenue. As a private company, financial details are limited, though the company has operated continuously since 1970. For capital equipment buyers, manufacturer financial stability matters because it affects warranty support, parts availability, and long-term software updates. Always verify the most recent financial position before signing a multi-year service contract.
How does Candela (Syneron) compare to competitors?
Candela (Syneron) competes across 4 device categories, with different competitive positions in each. In some categories the company leads on installed base; in others it's a value alternative or technology challenger. The competitive set should be evaluated category by category. Physicians considering a specific Candela (Syneron) platform should compare it directly against the other devices in that category, not against the manufacturer as a whole.
Where can I buy Candela (Syneron) devices?
Candela (Syneron) sells direct in some markets and through authorized dealers in others. Dealer presence and direct sales support vary by US region. For practices in major metro areas, multiple dealer relationships are typical. For practices in smaller markets, dealer access can be a limiting factor on training and service support. Verify dealer presence in your specific region before signing a purchase contract.
Does Candela (Syneron) offer financing or leasing?
Most major device manufacturers including Candela (Syneron) offer financing partnerships through third-party lenders, leasing arrangements with end-of-term buyout options, and trade-in programs for older devices. Terms vary by credit profile and total purchase size. Financing rates for capital medical equipment typically run 6-9% APR over five-year terms. Practices should always compare manufacturer financing against independent equipment lenders to ensure competitive rates.
What is Candela (Syneron) known for in 2026?
As of April 2026, Candela (Syneron) is known primarily for Alexandrite Laser, Nd:YAG Laser technologies and platforms across 4 device categories. The company's market position varies by category. In some segments Candela (Syneron) leads on installed base or clinical evidence depth. In others the company competes as a value alternative or technology challenger. The 56-year operating history (since 1970) gives the company an established reputation in the medical device buyer community, though buyer perception varies meaningfully by specialty and region.
Is Candela (Syneron) a good company to buy from in 2026?
Whether Candela (Syneron) is a good company to buy from depends on your specific platform need, regional dealer support, and total cost of ownership analysis. Strengths typically include Alexandrite Laser, the 56-year operating track record, and platform integration across the company's portfolio. Considerations: verify recent financial trajectory (private company financial transparency limited), confirm regional dealer presence and service capabilities, and check FDA MAUDE reports for recent adverse event signals. Compare against direct competitors in the specific category before committing.
What is Candela (Syneron)'s market position vs competitors in 2026?
Candela (Syneron)'s market position in 2026 varies by device category. The company competes across 4 device categories (laser hair removal, vascular pigment, tattoo removal), with different competitive positions in each. In some categories Candela (Syneron) leads on installed base or technology innovation. In others the company is a value alternative competing on price or specific features. To evaluate market position for the specific platform you are considering, request peer references in your specialty and region, check installed base data from industry publications, and compare clinical evidence depth across the competitive set.
What's the latest news from Candela (Syneron) in 2026?
Recent Candela (Syneron) updates relevant to capital equipment buyers in 2026 include periodic business updates, FDA labeling changes, software releases for installed devices, new applicator launches, and clinical evidence publications. Candela (Syneron) company press releases and trade press coverage are the most reliable sources for the latest operational and financial updates. Buyers evaluating multi-year service contracts should always check the most recent updates before committing because manufacturer trajectory affects long-term support quality.
Get the Device Quote Review Kit
Open the printable buyer checklist now, then get the planned Tuesday brief with price, FDA, safety, evidence, and manufacturer signals.
Free kit available immediately. Planned Tuesday brief. Unsubscribe anytime. Privacy.